Cas no 202197-78-2 (4-Chloro-7-iodoquinazoline)
4-Chloro-7-iodoquinazoline Chemical and Physical Properties
Names and Identifiers
-
- 4-Chloro-7-iodoquinazoline
- DB-106764
- Quinazoline, 4-chloro-7-iodo-
- SB10036
- AS-38868
- DTXSID80619235
- CS-0044967
- A929228
- 202197-78-2
- CIA19778
- WSSATKKSEZSYAN-UHFFFAOYSA-N
- AMY27451
- AKOS022182724
- MFCD08276179
- SCHEMBL145141
-
- MDL: MFCD08276179
- Inchi: 1S/C8H4ClIN2/c9-8-6-2-1-5(10)3-7(6)11-4-12-8/h1-4H
- InChI Key: WSSATKKSEZSYAN-UHFFFAOYSA-N
- SMILES: IC1C=CC2=C(N=CN=C2C=1)Cl
Computed Properties
- Exact Mass: 289.91077g/mol
- Monoisotopic Mass: 289.91077g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 12
- Rotatable Bond Count: 0
- Complexity: 167
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 3.2
- Topological Polar Surface Area: 25.8?2
4-Chloro-7-iodoquinazoline Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| abcr | AB447629-250 mg |
4-Chloro-7-iodoquinazoline; . |
202197-78-2 | 250MG |
€375.30 | 2023-07-18 | ||
| abcr | AB447629-1 g |
4-Chloro-7-iodoquinazoline; . |
202197-78-2 | 1g |
€697.10 | 2023-07-18 | ||
| Chemenu | CM372326-1g |
4-Chloro-7-iodoquinazoline |
202197-78-2 | 95%+ | 1g |
$744 | 2022-09-01 | |
| Enamine | EN300-256413-1g |
4-chloro-7-iodoquinazoline |
202197-78-2 | 1g |
$1085.0 | 2023-09-14 | ||
| Enamine | EN300-256413-5g |
4-chloro-7-iodoquinazoline |
202197-78-2 | 5g |
$2845.0 | 2023-09-14 | ||
| Enamine | EN300-256413-10g |
4-chloro-7-iodoquinazoline |
202197-78-2 | 10g |
$3578.0 | 2023-09-14 | ||
| eNovation Chemicals LLC | D571911-100mg |
4-chloro-7-iodoquinazoline |
202197-78-2 | 97% | 100mg |
$125 | 2024-05-23 | |
| eNovation Chemicals LLC | D571911-250MG |
4-chloro-7-iodoquinazoline |
202197-78-2 | 97% | 250mg |
$170 | 2024-05-23 | |
| eNovation Chemicals LLC | D571911-500MG |
4-chloro-7-iodoquinazoline |
202197-78-2 | 97% | 500mg |
$285 | 2024-05-23 | |
| eNovation Chemicals LLC | D571911-1G |
4-chloro-7-iodoquinazoline |
202197-78-2 | 97% | 1g |
$425 | 2024-05-23 |
4-Chloro-7-iodoquinazoline Related Literature
-
Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
-
Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
-
Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
-
Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
-
Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
Additional information on 4-Chloro-7-iodoquinazoline
4-Chloro-7-iodoquinazoline: A Comprehensive Overview
The compound 4-Chloro-7-iodoquinazoline, with the CAS number 202197-78-2, is a fascinating molecule that has garnered significant attention in the fields of organic chemistry and pharmacology. This compound belongs to the broader class of quinazolines, which are heterocyclic aromatic compounds with a wide range of applications in drug discovery and materials science. The presence of both a chlorine atom at position 4 and an iodine atom at position 7 introduces unique electronic and structural properties, making it a valuable compound for research and development.
The synthesis of 4-Chloro-7-iodoquinazoline typically involves multi-step reactions, often starting from readily available starting materials such as o-phenylenediamine derivatives. The introduction of halogen atoms at specific positions is achieved through halogenation reactions, which are carefully controlled to ensure regioselectivity. Recent advancements in catalytic methods have enabled more efficient and environmentally friendly syntheses, reducing the overall cost and improving the scalability of the process.
One of the most promising applications of 4-Chloro-7-iodoquinazoline lies in its potential as a building block for drug development. Quinazolines are known for their ability to interact with various biological targets, including kinases, which are critical in cellular signaling pathways. Studies have shown that 4-Chloro-7-iodoquinazoline derivatives exhibit potent inhibitory activity against several cancer-related kinases, making them strong candidates for anti-cancer drug development. Furthermore, the presence of halogen atoms enhances the molecule's pharmacokinetic properties, improving its bioavailability and efficacy.
In addition to its role in pharmacology, 4-Chloro-7-iodoquinazoline has also found applications in materials science. The compound's aromaticity and conjugated system make it an excellent candidate for use in organic electronics. Recent research has explored its potential as a component in light-emitting diodes (LEDs) and solar cells, where its electronic properties contribute to improved device performance. The ability to tune the molecule's electronic characteristics through halogen substitution further enhances its versatility in this field.
The structural uniqueness of 4-Chloro-7-iodoquinazoline also makes it an attractive substrate for studying chemical reactivity and reaction mechanisms. For instance, the iodine atom at position 7 can act as a leaving group in substitution reactions, enabling the formation of diverse derivatives. This property has been exploited in recent studies to develop novel synthetic pathways for complex molecules, showcasing the compound's value as a versatile intermediate.
From an environmental perspective, the synthesis and application of 4-Chloro-7-iodoquinazoline have been optimized to minimize ecological impact. Green chemistry principles have been incorporated into its production processes, reducing waste generation and energy consumption. These efforts align with global sustainability goals while maintaining the high quality and performance standards required for its intended applications.
In conclusion, 4-Chloro-7-iodoquinazoline stands out as a multifaceted compound with significant potential across various scientific disciplines. Its unique structure, derived from the strategic placement of chlorine and iodine atoms on a quinazoline backbone, endows it with remarkable chemical and biological properties. As research continues to uncover new applications and improve synthesis methods, this compound is poised to play an increasingly important role in advancing both medicine and materials science.
202197-78-2 (4-Chloro-7-iodoquinazoline) Related Products
- 2148-57-4(4,7-Dichloroquinazoline)
- 959237-34-4(2,4-Dichloro-7-iodoquinazoline)
- 351426-06-7(4-Chloro-6-iodo-2-methylquinazoline)
- 351426-09-0(Quinazoline,4-chloro-2-ethyl-6-iodo-)
- 2148-55-2(4,5-Dichloroquinazoline)
- 98436-53-4(Quinazoline,4-chloro-6,8-diiodo-)
- 98556-31-1(4-Chloro-6-iodoquinazoline)
- 7253-22-7(4,6-Dichloroquinazoline)
- 5190-68-1(4-chloroquinazoline)
- 74173-76-5(2,4-Dichloro-6-iodoquinazoline)